• 繁

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Individual investors who hold 37% of Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) gained 12%, insiders profited as well

    Simply Wall St·12/31/2025 22:43:43
    語音播報

    Key Insights

    This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

    Every investor in Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are individual investors with 37% ownership. Put another way, the group faces the maximum upside potential (or downside risk).

    Following a 12% increase in the stock price last week, individual investors profited the most, but insiders who own 28% stock also stood to gain from the increase.

    In the chart below, we zoom in on the different ownership groups of Shanghai HeartCare Medical Technology.

    Check out our latest analysis for Shanghai HeartCare Medical Technology

    ownership-breakdown
    SEHK:6609 Ownership Breakdown December 31st 2025

    What Does The Institutional Ownership Tell Us About Shanghai HeartCare Medical Technology?

    Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

    As you can see, institutional investors have a fair amount of stake in Shanghai HeartCare Medical Technology. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Shanghai HeartCare Medical Technology, (below). Of course, keep in mind that there are other factors to consider, too.

    earnings-and-revenue-growth
    SEHK:6609 Earnings and Revenue Growth December 31st 2025

    Shanghai HeartCare Medical Technology is not owned by hedge funds. With a 22% stake, CEO Guohui Wang is the largest shareholder. Lyfe Capital is the second largest shareholder owning 15% of common stock, and Wisary Limited holds about 7.1% of the company stock.

    On looking further, we found that 54% of the shares are owned by the top 5 shareholders. In other words, these shareholders have a meaningful say in the decisions of the company.

    Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There is some analyst coverage of the stock, but it could still become more well known, with time.

    Insider Ownership Of Shanghai HeartCare Medical Technology

    While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

    Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

    Our most recent data indicates that insiders own a reasonable proportion of Shanghai HeartCare Medical Technology Corporation Limited. It has a market capitalization of just HK$2.0b, and insiders have HK$573m worth of shares in their own names. We would say this shows alignment with shareholders, but it is worth noting that the company is still quite small; some insiders may have founded the business. You can click here to see if those insiders have been buying or selling.

    General Public Ownership

    The general public, who are usually individual investors, hold a 37% stake in Shanghai HeartCare Medical Technology. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

    Private Equity Ownership

    Private equity firms hold a 15% stake in Shanghai HeartCare Medical Technology. This suggests they can be influential in key policy decisions. Some investors might be encouraged by this, since private equity are sometimes able to encourage strategies that help the market see the value in the company. Alternatively, those holders might be exiting the investment after taking it public.

    Private Company Ownership

    Our data indicates that Private Companies hold 11%, of the company's shares. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

    Next Steps:

    While it is well worth considering the different groups that own a company, there are other factors that are even more important. Take risks for example - Shanghai HeartCare Medical Technology has 1 warning sign we think you should be aware of.

    Ultimately the future is most important. You can access this free report on analyst forecasts for the company.

    NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.